We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.125 | -2.22% | 5.50 | 5.25 | 5.75 | 5.625 | 5.375 | 5.625 | 726,921 | 11:40:08 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0447 | -1.20 | 6.18M |
From Apr 2019 to Apr 2024
TIDMGDR
RNS Number : 8385W
Genedrive PLC
17 November 2017
For release: 17 November 2017
2017 Annual Report and AGM Notice
genedrive plc (LSE: GDR), the near patient molecular diagnostics company, gives notice that copies of its 2017 Annual Report and Notice of the 2017 Annual General Meeting have been posted to shareholders. The AGM will be held at 12:00 on 29 November 2017 at the Company's premises at The Innovation Centre, 48 Grafton Street, Manchester M13 9XX.
Copies of these documents may be found on the Company's website (www.genedriveplc.com)
- Ends -
For further details please contact:
genedrive plc +44 (0)161 989 0245 David Budd: CEO Matthew Fowler: CFO Peel Hunt LLP James Steel +44 (0)207 418 8900 Oliver Jackson Consilium Strategic Communications +44 (0)203 709 5700 Chris Gardner Matthew Neal Laura Thornton genedrive@consilium-comms.com
Notes to Editors
About genedrive plc
genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Genedrive(R) platform and MTB/RIF test have been launched in India and a Genedrive(R) HCV test has received CE-IVD Certification.
Further details can be found at: www.genedriveplc.com and www.genedrive.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOABBBDBXDBBGRR
(END) Dow Jones Newswires
November 17, 2017 06:25 ET (11:25 GMT)
1 Year Genedrive Chart |
1 Month Genedrive Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
